Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells

被引:21
作者
Killestein, J
Rep, MHG
Barkhof, F
Roos, MTL
Adèr, HJ
van Lier, RAW
Polman, CH
机构
[1] VU Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands
[2] Univ Amsterdam, Expt & Clin Immunol Lab, NL-1012 WX Amsterdam, Netherlands
[3] VU Med Ctr, MS MRI Ctr, NL-1007 MB Amsterdam, Netherlands
[4] VU MEd Ctr, Fac Med, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands
[5] Univ Amsterdam, Dept Immunobiol, CLB, NL-1012 WX Amsterdam, Netherlands
关键词
multiple sclerosis; MRI; disease activity; T cells; cytokines;
D O I
10.1016/S0165-5728(01)00346-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The role of T cell subpopulations and their ability to produce immunoregulatory cytokines has been extensively studied in multiple sclerosis (MS). However, the exact mechanisms by which T cells and cytokines contribute to disease activity remain to be clarified. Objectives: To analyze the longitudinal relation between markers of T cell activation and differentiation and disease activity in MS patients. Methods: During a period of 9 months. clinical disease activity was scored, monthly MRI scans were performed, and blood was taken for immune measurements in a group of 13 untreated clinically definite MS patients. Results: Disease activity, as measured by the occurrence of active MRI lesions, is associated with a significant transient decrease in both T cells producing interferon-gamma (IFN-gamma) and T cells producing interleukin (IL)-4. Conclusions: Our results suggest that MRI-documented disease activity is associated with a transient decrease in circulating cytokine producing T cells, possibly due to the migration of activated T cells into the CNS. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:286 / 294
页数:9
相关论文
共 28 条
[1]  
Becher B, 1999, ANN NEUROL, V45, P247, DOI 10.1002/1531-8249(199902)45:2<247::AID-ANA16>3.0.CO
[2]  
2-U
[3]   INCREASED PRODUCTION OF INTERFERON GAMMA AND TUMOR NECROSIS FACTOR PRECEDES CLINICAL MANIFESTATION IN MULTIPLE-SCLEROSIS - DO CYTOKINES TRIGGER OFF EXACERBATIONS [J].
BECK, J ;
RONDOT, P ;
CATINOT, L ;
FALCOFF, E ;
KIRCHNER, H ;
WIETZERBIN, J .
ACTA NEUROLOGICA SCANDINAVICA, 1988, 78 (04) :318-323
[4]   A FUNCTIONAL DICHOTOMY IN CD4+ LYMPHOCYTES-T [J].
BOTTOMLY, K .
IMMUNOLOGY TODAY, 1988, 9 (09) :268-274
[5]   DECREASED CD3-MEDIATED INTERFERON-GAMMA PRODUCTION IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS [J].
BROD, SA ;
KHAN, M ;
BRIGHT, J ;
SRIRAM, S ;
MARSHALL, GJ ;
HENNINGER, EM ;
KERMAN, RH ;
WOLINSKY, JS .
ANNALS OF NEUROLOGY, 1995, 37 (04) :546-549
[6]   The Th1/Th2 balance in autoimmunity [J].
Charlton, B ;
Lafferty, KJ .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (06) :793-798
[7]   Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: Enhancement by monoclonal antibodies against interferon-gamma [J].
Heremans, H ;
Dillen, C ;
Groenen, M ;
Martens, E ;
Billiau, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (10) :2393-2398
[8]   Interferon-gamma confers resistance to experimental allergic encephalomyelitis [J].
Krakowski, M ;
Owens, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) :1641-1646
[9]   INCREASED TRANSFORMING GROWTH-FACTOR-BETA, INTERLEUKIN-4, AND INTERFERON-GAMMA IN MULTIPLE-SCLEROSIS [J].
LINK, J ;
SODERSTROM, M ;
OLSSON, T ;
HOJEBERG, B ;
LJUNGDAHL, A ;
LINK, H .
ANNALS OF NEUROLOGY, 1994, 36 (03) :379-386
[10]   Cytokines and immunity in multiple sclerosis: the dual signal hypothesis [J].
Martino, G ;
Furlan, R ;
Brambilla, E ;
Bergami, A ;
Ruffini, F ;
Gironi, M ;
Poliani, PL ;
Grimaldi, LME .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 109 (01) :3-9